Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine in Body Focused Repetitive Behaviors
NCT04792645Phase 2Completed
- Sponsor
- University of Chicago
- Start
- Jun 2021
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in trichotillomania (TTM) and Excoriation disorder (SPD) comparing Memantine with Placebo (2 arms). Primary endpoint: National Institute of Mental Health Symptom Severity Scale at 8 weeks. Started Jun 2021; status: completed.
02
Drugs
memantine
03
Conditions
trichotillomania (TTM)Excoriation disorder (SPD)
Beyond the preview
Go deeper on NCT04792645.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04792645.